Juma Obayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Juma Obayashi has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Hiroaki Kitagawa
Department of Pediatric Surgery, St. Marianna University School of Medicine, Kawasaki, Japan
6 shared publications Junki Koike
Department of Diagnostic Pathology, St. Marianna University School of Medicine, Kanagawa, Japan
5 shared publicationsKunihide Tanaka
5 shared publications- Shigeyuki Furuta
Department of Pediatric Surgery, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae, Kawasaki 216-8511, Kanagawa, Japan
5 shared publications Koji Fukumoto
Department of Pediatric Surgery, Shizuoka Children’s Hospital, Shizuoka, Japan
4 shared publicationsMasayuki Takagi
Department of Pathology, St. Marianna University School of Medicine, Kawasaki, Japan
4 shared publications
Latest Publications
- 11 September 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1) , 398
Evaluation of atelocollagen implant therapy for a rabbit model of acquired tracheomalacia following tracheostomy
Purpose This study evaluated whether local atelocollagen gel administration prevented airway collapse in a rabbit model of acquired tracheomalacia after tracheostomy. Methods Japanese white rabbits (≥ 20 weeks) underwent anterior resection of the second–fourth tracheal rings with mucosal preservation. Group A received 1 mL of 3% atelocollagen around the trachea, whereas Group B was untreated. Bronchoscopy was performed preoperatively (Term 1), immediately postoperatively (Term 2), and 3–4 months postoperatively (Term 3). The tracheal lumen area was measured using negative-pressure suction. Results Six of seven rabbits in Group A and five of six rabbits in Group B survived. At 30 cmHg, lumen area (%) in Group A was 90.1 ± 19.9 (Term 1), 48.0 ± 40.4 (Term 2), and 69.0 ± 50.3 (Term 3), versus 99.4 ± 7.8, 53.4 ± 20.0, and 15.0 ± 18.8 in Group B. No differences were observed at Terms 1 or 2. At Term 3, lumen area decreased with increasing suction in Group B but was relatively preserved in Group A. Lumen area ≥ 50% at 30 cmHg was observed in 4/6 (66.7%) in Group A and 0/5 (0%) in Group B. Conclusion Local atelocollagen administration may attenuate airway collapse in tracheomalacia at 3–4 months.
- 11 September 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1) , 398
Evaluation of atelocollagen implant therapy for a rabbit model of acquired tracheomalacia following tracheostomy
Purpose This study evaluated whether local atelocollagen gel administration prevented airway collapse in a rabbit model of acquired tracheomalacia after tracheostomy. Methods Japanese white rabbits (≥ 20 weeks) underwent anterior resection of the second–fourth tracheal rings with mucosal preservation. Group A received 1 mL of 3% atelocollagen around the trachea, whereas Group B was untreated. Bronchoscopy was performed preoperatively (Term 1), immediately postoperatively (Term 2), and 3–4 months postoperatively (Term 3). The tracheal lumen area was measured using negative-pressure suction. Results Six of seven rabbits in Group A and five of six rabbits in Group B survived. At 30 cmHg, lumen area (%) in Group A was 90.1 ± 19.9 (Term 1), 48.0 ± 40.4 (Term 2), and 69.0 ± 50.3 (Term 3), versus 99.4 ± 7.8, 53.4 ± 20.0, and 15.0 ± 18.8 in Group B. No differences were observed at Terms 1 or 2. At Term 3, lumen area decreased with increasing suction in Group B but was relatively preserved in Group A. Lumen area ≥ 50% at 30 cmHg was observed in 4/6 (66.7%) in Group A and 0/5 (0%) in Group B. Conclusion Local atelocollagen administration may attenuate airway collapse in tracheomalacia at 3–4 months.
- Open Access
- 13 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2940
A Review of Indications and Technical Considerations of Endoscopic Balloon Dilation for Pediatric Subglottic Stenosis
Pediatric subglottic stenosis (SGS) remains a significant cause of upper airway obstruction in infants and children, most commonly resulting from prolonged endotracheal intubation. Although open airway reconstruction procedures such as laryngotracheal reconstruction (LTR) and partial cricotracheal resection (PCTR) provide definitive treatment for severe disease, their invasiveness and the burden of postoperative management have prompted increasing interest in less invasive approaches. Endoscopic balloon dilation has emerged as an effective therapeutic option, particularly for early-stage, short-segment, and soft acquired stenosis. This review summarizes the pathophysiology, clinical presentation, and severity assessment of pediatric SGS, and discusses the evolution of surgical management with particular emphasis on the role of balloon dilation. Technical aspects—including balloon sizing, adjunctive radial incision, dilation protocols, and local pharmacologic therapies—are outlined. Endoscopic balloon dilation is most effective in carefully selected patients, particularly those with early-stage and less severe stenosis. While it can significantly reduce the need for open airway reconstruction, recurrence remains a key limitation, necessitating careful patient selection and long-term follow-up. This article represents a narrative review of the current literature combined with the authors’ clinical experience.
- 13 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2940
Open AccessA Review of Indications and Technical Considerations of Endoscopic Balloon Dilation for Pediatric Subglottic Stenosis
Pediatric subglottic stenosis (SGS) remains a significant cause of upper airway obstruction in infants and children, most commonly resulting from prolonged endotracheal intubation. Although open airway reconstruction procedures such as laryngotracheal reconstruction (LTR) and partial cricotracheal resection (PCTR) provide definitive treatment for severe disease, their invasiveness and the burden of postoperative management have prompted increasing interest in less invasive approaches. Endoscopic balloon dilation has emerged as an effective therapeutic option, particularly for early-stage, short-segment, and soft acquired stenosis. This review summarizes the pathophysiology, clinical presentation, and severity assessment of pediatric SGS, and discusses the evolution of surgical management with particular emphasis on the role of balloon dilation. Technical aspects—including balloon sizing, adjunctive radial incision, dilation protocols, and local pharmacologic therapies—are outlined. Endoscopic balloon dilation is most effective in carefully selected patients, particularly those with early-stage and less severe stenosis. While it can significantly reduce the need for open airway reconstruction, recurrence remains a key limitation, necessitating careful patient selection and long-term follow-up. This article represents a narrative review of the current literature combined with the authors’ clinical experience.
- Open Access
- 1 April 2026
- Published by AME Publishing Company in AME Surgical Journal
- Vol. 6, 12
Does prolonged postoperative intravenous antibiotic therapy prevent intra-abdominal abscess after pediatric perforated appendicitis?—a retrospective comparative study
Background: Postoperative intra-abdominal abscess is a frequent complication of perforated appendicitis. This study aimed to evaluate the effectiveness of prolonged postoperative intravenous antibiotics in preventing abscess formation in pediatric perforated appendicitis. Methods: A retrospective review was performed on pediatric patients who underwent appendectomy for perforated appendicitis between 2013 and 2022 at St. Marianna University School of Medicine. Patients were divided into two groups based on the duration of postoperative intravenous antibiotic therapy: Group A (≥7 days) and Group B (Results: Forty patients comprised Group A, and 22 patients comprised Group B. There were no statistically significant differences in patient demographics; for instance, the groups did not differ in terms of age, gender, or preoperative white blood cell count. In contrast, C-reactive protein levels were significantly higher in Group A (P=0.02). Postoperative abscesses developed in 4 patients (10%) in Group A and 3 patients (14%) in Group B (P=0.69). The average time to abscess diagnosis was 17.8±8.3 days postoperatively in Group A compared to 6.0±3.6 days in Group B. Additionally, the number of patients diagnosed with abscesses after discontinuation of antibiotics was 3 (7.3%) in Group A and 1 (4.5%) in Group B. Conclusions: Prolonged postoperative intravenous antibiotic therapy was not associated with a lower incidence of intra-abdominal abscess in this cohort and may delay diagnosis. These findings should be interpreted cautiously given the retrospective design.
- 1 April 2026
- Published by AME Publishing Company in AME Surgical Journal
- Vol. 6, 12
Open AccessDoes prolonged postoperative intravenous antibiotic therapy prevent intra-abdominal abscess after pediatric perforated appendicitis?—a retrospective comparative study
Background: Postoperative intra-abdominal abscess is a frequent complication of perforated appendicitis. This study aimed to evaluate the effectiveness of prolonged postoperative intravenous antibiotics in preventing abscess formation in pediatric perforated appendicitis. Methods: A retrospective review was performed on pediatric patients who underwent appendectomy for perforated appendicitis between 2013 and 2022 at St. Marianna University School of Medicine. Patients were divided into two groups based on the duration of postoperative intravenous antibiotic therapy: Group A (≥7 days) and Group B (Results: Forty patients comprised Group A, and 22 patients comprised Group B. There were no statistically significant differences in patient demographics; for instance, the groups did not differ in terms of age, gender, or preoperative white blood cell count. In contrast, C-reactive protein levels were significantly higher in Group A (P=0.02). Postoperative abscesses developed in 4 patients (10%) in Group A and 3 patients (14%) in Group B (P=0.69). The average time to abscess diagnosis was 17.8±8.3 days postoperatively in Group A compared to 6.0±3.6 days in Group B. Additionally, the number of patients diagnosed with abscesses after discontinuation of antibiotics was 3 (7.3%) in Group A and 1 (4.5%) in Group B. Conclusions: Prolonged postoperative intravenous antibiotic therapy was not associated with a lower incidence of intra-abdominal abscess in this cohort and may delay diagnosis. These findings should be interpreted cautiously given the retrospective design.
- Open Access
- 9 January 2026
- Published by MDPI AG in Journal of Developmental Biology
- Vol. 14 (1) , 5
Influence of Obstructive Uropathy on Cyst Formation and Nephrogenesis: Insights from a Fetal Lamb Model
Obstructive uropathy (OU) during fetal development induces a fetal cystic dysplastic kidney. The mechanisms of cyst formation and the onset of renal dysfunction remain unclear. Determining whether nephrogenic potential persists during fetal life may suggest whether early intervention could preserve renal development. We aimed to evaluate residual nephrogenic activity in fetal cystic dysplastic kidneys using β-catenin and CD10 immunostaining, and to assess whether the site of obstruction influences cystogenesis. After appropriate approval, 20 timed-gestation fetal lambs had OU created at 60 days. Males underwent urethral and urachal ligation (n = 8, 3 lost), and females underwent unilateral ureteric ligation (n = 8, 1 lost). Fetuses were sacrificed at 80 days (n = 6) and 140 days (term, n = 10), comparing kidneys with normal controls of the same gestational age using immunohistochemical staining for β-catenin and CD10. Developing fetal cystic dysplastic kidneys were identified at 80 days. β-catenin staining showed the absence of granular cytoplasmic expression in cystic regions, indicating arrested nephrogenesis. In male models, cysts originated exclusively from proximal tubules. Female models exhibited mixed proximal and distal tubular involvement. CD10 staining confirmed the loss of proximal tubular markers. Renal development remained arrested at term. Cyst formation disrupts renal development early in gestation, which persists until term. Differences in cystogenesis between the models suggest that the site of obstruction influences pathogenic mechanisms.
- 9 January 2026
- Published by MDPI AG in Journal of Developmental Biology
- Vol. 14 (1) , 5
Open AccessInfluence of Obstructive Uropathy on Cyst Formation and Nephrogenesis: Insights from a Fetal Lamb Model
Obstructive uropathy (OU) during fetal development induces a fetal cystic dysplastic kidney. The mechanisms of cyst formation and the onset of renal dysfunction remain unclear. Determining whether nephrogenic potential persists during fetal life may suggest whether early intervention could preserve renal development. We aimed to evaluate residual nephrogenic activity in fetal cystic dysplastic kidneys using β-catenin and CD10 immunostaining, and to assess whether the site of obstruction influences cystogenesis. After appropriate approval, 20 timed-gestation fetal lambs had OU created at 60 days. Males underwent urethral and urachal ligation (n = 8, 3 lost), and females underwent unilateral ureteric ligation (n = 8, 1 lost). Fetuses were sacrificed at 80 days (n = 6) and 140 days (term, n = 10), comparing kidneys with normal controls of the same gestational age using immunohistochemical staining for β-catenin and CD10. Developing fetal cystic dysplastic kidneys were identified at 80 days. β-catenin staining showed the absence of granular cytoplasmic expression in cystic regions, indicating arrested nephrogenesis. In male models, cysts originated exclusively from proximal tubules. Female models exhibited mixed proximal and distal tubular involvement. CD10 staining confirmed the loss of proximal tubular markers. Renal development remained arrested at term. Cyst formation disrupts renal development early in gestation, which persists until term. Differences in cystogenesis between the models suggest that the site of obstruction influences pathogenic mechanisms.
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1)
Incidence and Long‐Term Outcomes of Pediatric Tracheostomy in Japan: A Cohort Study Using a Japanese Claims Database
Background: Epidemiological data on pediatric tracheostomy are limited, particularly in Asia. We estimated the incidence and evaluated long‐term post‐tracheostomy outcomes and their predictors using a large Japanese claims database. Methods: We used the Japanese administrative claims database (JMDC) from 2005 to 2025. All individuals aged < 20 years observed during continuous enrollment contributed person‐time to the incidence analysis. Individuals who underwent incident tracheostomy constituted the post‐tracheostomy cohort. Cumulative incidences of decannulation and death were estimated using competing‐risk methods, and predictors of each outcome were evaluated with cause‐specific Cox proportional hazards models. Results: Among 6,046,879 individuals aged < 20 years, 1032 underwent incident tracheostomy and constituted the post‐tracheostomy cohort (median age, 1.2 years [IQR, 0.4–12.6]). The incidence was 4.0 (95% CI, 3.7–4.2) per 100,000 person‐years; it was highest in infants (< 1 year: 42.4) and increased modestly in late adolescence (15–19 years: 2.8). The cumulative incidence of decannulation was 22.9% (95% CI, 20.3–25.5) at 1 year and 40.6% (95% CI, 37.1–44.1) at 5 years; the cumulative incidence of death was 12.9% (95% CI, 10.7–15.0) at 1 year and 22.2% (95% CI, 19.4–25.1) at 5 years. Older age (6–19 years) and trauma were associated with earlier decannulation, whereas malignancy, cardiovascular disease, congenital/genetic comorbidity, and post–cardiac arrest diagnosis were associated with earlier death. Conclusion: The incidence of pediatric tracheostomy peaked in infancy and increased modestly in late adolescence. During long‐term follow‐up, substantial proportions of patients experienced decannulation or death, with distinct predictors for each outcome.
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1)
Incidence and Long‐Term Outcomes of Pediatric Tracheostomy in Japan: A Cohort Study Using a Japanese Claims Database
Background: Epidemiological data on pediatric tracheostomy are limited, particularly in Asia. We estimated the incidence and evaluated long‐term post‐tracheostomy outcomes and their predictors using a large Japanese claims database. Methods: We used the Japanese administrative claims database (JMDC) from 2005 to 2025. All individuals aged < 20 years observed during continuous enrollment contributed person‐time to the incidence analysis. Individuals who underwent incident tracheostomy constituted the post‐tracheostomy cohort. Cumulative incidences of decannulation and death were estimated using competing‐risk methods, and predictors of each outcome were evaluated with cause‐specific Cox proportional hazards models. Results: Among 6,046,879 individuals aged < 20 years, 1032 underwent incident tracheostomy and constituted the post‐tracheostomy cohort (median age, 1.2 years [IQR, 0.4–12.6]). The incidence was 4.0 (95% CI, 3.7–4.2) per 100,000 person‐years; it was highest in infants (< 1 year: 42.4) and increased modestly in late adolescence (15–19 years: 2.8). The cumulative incidence of decannulation was 22.9% (95% CI, 20.3–25.5) at 1 year and 40.6% (95% CI, 37.1–44.1) at 5 years; the cumulative incidence of death was 12.9% (95% CI, 10.7–15.0) at 1 year and 22.2% (95% CI, 19.4–25.1) at 5 years. Older age (6–19 years) and trauma were associated with earlier decannulation, whereas malignancy, cardiovascular disease, congenital/genetic comorbidity, and post–cardiac arrest diagnosis were associated with earlier death. Conclusion: The incidence of pediatric tracheostomy peaked in infancy and increased modestly in late adolescence. During long‐term follow‐up, substantial proportions of patients experienced decannulation or death, with distinct predictors for each outcome.
- 27 August 2025
- Published by Springer Nature in Pediatric Surgery International
- Vol. 41 (1) , 1-10
Establishment and evaluation of an animal model of acquired tracheomalacia following tracheostomy in rabbits
Purpose Acquired tracheomalacia (TM) following tracheostomy can hinder decannulation and affect the quality of life of pediatric patients. Therefore, a reproducible animal model of type III TM is required for further research and therapeutic development. Methods We established a rabbit model of acquired TM by resecting the anterior walls of the 2nd to 4th tracheal cartilage rings, while preserving the mucosa. Bronchoscopic evaluations were conducted at three time points: before surgery (term 1), immediately after surgery (term 2), and 3–4 months post-surgery (term 3). The area of the tracheal lumen was measured under varying negative suction pressures using image analysis. Results Five of the six rabbits survived and successfully modeled TM. Progressive luminal narrowing was observed, particularly at term 3, where the area decreased to 15.0 ± 18.8% under 30 cmHg suction. Compared with term 1, the same suction pressures resulted in a greater collapse at terms 2 and 3, indicating gradual structural weakening. No respiratory symptoms were observed during the follow-up. Conclusion This rabbit model of acquired type III TM is reproducible and enables the quantitative evaluation of airway collapsibility. This may be useful for investigating TM pathophysiology and testing new treatment strategies.
- 27 August 2025
- Published by Springer Nature in Pediatric Surgery International
- Vol. 41 (1) , 1-10
Establishment and evaluation of an animal model of acquired tracheomalacia following tracheostomy in rabbits
Purpose Acquired tracheomalacia (TM) following tracheostomy can hinder decannulation and affect the quality of life of pediatric patients. Therefore, a reproducible animal model of type III TM is required for further research and therapeutic development. Methods We established a rabbit model of acquired TM by resecting the anterior walls of the 2nd to 4th tracheal cartilage rings, while preserving the mucosa. Bronchoscopic evaluations were conducted at three time points: before surgery (term 1), immediately after surgery (term 2), and 3–4 months post-surgery (term 3). The area of the tracheal lumen was measured under varying negative suction pressures using image analysis. Results Five of the six rabbits survived and successfully modeled TM. Progressive luminal narrowing was observed, particularly at term 3, where the area decreased to 15.0 ± 18.8% under 30 cmHg suction. Compared with term 1, the same suction pressures resulted in a greater collapse at terms 2 and 3, indicating gradual structural weakening. No respiratory symptoms were observed during the follow-up. Conclusion This rabbit model of acquired type III TM is reproducible and enables the quantitative evaluation of airway collapsibility. This may be useful for investigating TM pathophysiology and testing new treatment strategies.
- 2 September 2023
- Published by Springer Nature in Pediatric Surgery International
- Vol. 39 (1) , 1-7
Safety evaluation of a stepwise tracheostomy decannulation program in pediatric patients
Purpose In the event of failed tracheostomy decannulation, patients might have a tragic course of events. We retrospectively evaluated our stepwise tracheostomy decannulation program and examined its safety. Methods A 12-year retrospective study of pediatric patients was conducted. The decannulation program was performed on patients who had airway patency by laryngobronchoscopy and whose cannula could be capped during the day. A stepwise decannulation program was performed: continuous 48-h capping trial during hospitalization (Phase 1), removal of the tracheostomy tube for 48 h during hospitalization (Phase 2), and outpatient observation (Phase 3). If a persistent tracheocutaneous fistula existed, the fistula was closed by surgery (Phase 4). Results The 77 patients in the study underwent 86 trials. The age at the first time of the decannulation program was 6.5 ± 3.6 years. Sixteen trials failed (18.6%): 8 trials in Phase 1, 2 trials in Phase 2, 4 trials in Phase 3, and 2 trials in Phase 4. Most decannulation failures were due to desaturation in Phase 1/2 and dyspnea in Phase 3/4. The time to reintubation after decannulation was 15–383 days in Phase 3/4. Conclusions Patients could fail at every phase of the program, suggesting that a stepwise decannulation program contributes to safety.
- 2 September 2023
- Published by Springer Nature in Pediatric Surgery International
- Vol. 39 (1) , 1-7
Safety evaluation of a stepwise tracheostomy decannulation program in pediatric patients
Purpose In the event of failed tracheostomy decannulation, patients might have a tragic course of events. We retrospectively evaluated our stepwise tracheostomy decannulation program and examined its safety. Methods A 12-year retrospective study of pediatric patients was conducted. The decannulation program was performed on patients who had airway patency by laryngobronchoscopy and whose cannula could be capped during the day. A stepwise decannulation program was performed: continuous 48-h capping trial during hospitalization (Phase 1), removal of the tracheostomy tube for 48 h during hospitalization (Phase 2), and outpatient observation (Phase 3). If a persistent tracheocutaneous fistula existed, the fistula was closed by surgery (Phase 4). Results The 77 patients in the study underwent 86 trials. The age at the first time of the decannulation program was 6.5 ± 3.6 years. Sixteen trials failed (18.6%): 8 trials in Phase 1, 2 trials in Phase 2, 4 trials in Phase 3, and 2 trials in Phase 4. Most decannulation failures were due to desaturation in Phase 1/2 and dyspnea in Phase 3/4. The time to reintubation after decannulation was 15–383 days in Phase 3/4. Conclusions Patients could fail at every phase of the program, suggesting that a stepwise decannulation program contributes to safety.
- Open Access
- 28 August 2023
- Published by Springer Nature in Research Square
Safety evaluation of a stepwise tracheostomy decannulation program in pediatric patients
Purpose In the event of failed tracheostomy decannulation, patients might have a tragic course of events. We retrospectively evaluated our stepwise tracheostomy decannulation program and examined its safety.Methods A 12-year retrospective study of pediatric patients was conducted. The decannulation program was performed on patients who had airway patency by laryngobronchoscopy and whose cannula could be capped during the day. A stepwise decannulation program was performed: continuous 48-hour capping trial during hospitalization (Phase 1), removal of the tracheostomy tube for 48 hours during hospitalization (Phase 2), and outpatient observation (Phase 3). If a persistent tracheocutaneous fistula existed, the fistula was closed by surgery (Phase 4).Results The 77 patients in the study underwent 86 trials. The age at the first time of the decannulation program was 6.5 ± 3.6 years old. Sixteen trials failed (18.6%): 8 trials in Phase 1, 2 trials in Phase 2, 4 trials in Phase 3, and 2 trials in Phase 4. Most decannulation failures were due to desaturation in Phase 1/2 and dyspnea in Phase 3/4. The time to reintubation after decannulation was 15–383 days in Phase 3/4.Conclusions Patients could fail at every phase of the program, suggesting that a stepwise decannulation program contributes to safety.
- 28 August 2023
- Published by Springer Nature in Research Square
Open AccessSafety evaluation of a stepwise tracheostomy decannulation program in pediatric patients
Purpose In the event of failed tracheostomy decannulation, patients might have a tragic course of events. We retrospectively evaluated our stepwise tracheostomy decannulation program and examined its safety.Methods A 12-year retrospective study of pediatric patients was conducted. The decannulation program was performed on patients who had airway patency by laryngobronchoscopy and whose cannula could be capped during the day. A stepwise decannulation program was performed: continuous 48-hour capping trial during hospitalization (Phase 1), removal of the tracheostomy tube for 48 hours during hospitalization (Phase 2), and outpatient observation (Phase 3). If a persistent tracheocutaneous fistula existed, the fistula was closed by surgery (Phase 4).Results The 77 patients in the study underwent 86 trials. The age at the first time of the decannulation program was 6.5 ± 3.6 years old. Sixteen trials failed (18.6%): 8 trials in Phase 1, 2 trials in Phase 2, 4 trials in Phase 3, and 2 trials in Phase 4. Most decannulation failures were due to desaturation in Phase 1/2 and dyspnea in Phase 3/4. The time to reintubation after decannulation was 15–383 days in Phase 3/4.Conclusions Patients could fail at every phase of the program, suggesting that a stepwise decannulation program contributes to safety.
- 1 January 2023
- Published by Wiley in Pediatrics International
- Vol. 65 (1) , e15657
A case of ruptured mediastinal teratoma with high levels of lipase in the cyst
- 1 January 2023
- Published by Wiley in Pediatrics International
- Vol. 65 (1) , e15657
A case of ruptured mediastinal teratoma with high levels of lipase in the cyst
- 1 January 2023
- Published by Wiley in Pediatrics International
- Vol. 65 (1) , e15547
The comorbidities of recurrent inguinal hernia in children: A systematic review
Background: Higher risk of recurrence has been reported in pediatric inguinal hernia patients with specific comorbidities. The purpose of this systematic review was to investigate which comorbidities predispose to recurrent pediatric inguinal hernias (RPIHs).Methods: A comprehensive search of six databases was performed, reviewing the literature to date on RPIHs and the co‐occurrence of comorbidities. English‐language publications were considered for inclusion. The primary surgical technique (e.g., Potts procedure or laparoscopic repair) was not considered.Results: Fourteen articles published between 1967 and 2021 fulfilled the inclusion criteria and did not meet the exclusion criteria. They reported a total of 86 patients diagnosed with RPIHs with 99 comorbidities. Thirty‐six percent of patients had conditions with increased intra‐abdominal pressure, such as ventriculoperitoneal shunt for hydrocephalus, posterior urethral valves, bladder exstrophy, seizure disorder, asthma, using continuous positive airway pressure for respiratory distress syndrome, and gastroesophageal reflux disease. Twenty‐eight percent of patients had diseases with weakness of the anterior abdominal wall, specifically mucopolysaccharidosis, giant omphalocele, Ehlers–Danlos syndrome, connective‐tissue disorders, and segmental spinal dysgenesis.Conclusions: The main comorbidities of RPIHs were conditions with increased intra‐abdominal pressure and weakness of the anterior abdominal wall. Although these comorbidities are rare, the risk of recurrence must be noted.
- 1 January 2023
- Published by Wiley in Pediatrics International
- Vol. 65 (1) , e15547
The comorbidities of recurrent inguinal hernia in children: A systematic review
Background: Higher risk of recurrence has been reported in pediatric inguinal hernia patients with specific comorbidities. The purpose of this systematic review was to investigate which comorbidities predispose to recurrent pediatric inguinal hernias (RPIHs).Methods: A comprehensive search of six databases was performed, reviewing the literature to date on RPIHs and the co‐occurrence of comorbidities. English‐language publications were considered for inclusion. The primary surgical technique (e.g., Potts procedure or laparoscopic repair) was not considered.Results: Fourteen articles published between 1967 and 2021 fulfilled the inclusion criteria and did not meet the exclusion criteria. They reported a total of 86 patients diagnosed with RPIHs with 99 comorbidities. Thirty‐six percent of patients had conditions with increased intra‐abdominal pressure, such as ventriculoperitoneal shunt for hydrocephalus, posterior urethral valves, bladder exstrophy, seizure disorder, asthma, using continuous positive airway pressure for respiratory distress syndrome, and gastroesophageal reflux disease. Twenty‐eight percent of patients had diseases with weakness of the anterior abdominal wall, specifically mucopolysaccharidosis, giant omphalocele, Ehlers–Danlos syndrome, connective‐tissue disorders, and segmental spinal dysgenesis.Conclusions: The main comorbidities of RPIHs were conditions with increased intra‐abdominal pressure and weakness of the anterior abdominal wall. Although these comorbidities are rare, the risk of recurrence must be noted.